Squamous cell carcinoma arising in long-standing necrobiosis lipoidica.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 15009305)

Published in J Eur Acad Dermatol Venereol on March 01, 2004

Authors

J Santos-Juanes1, C Galache, J R Curto, M P Carrasco, A Ribas, J Sánchez del Río

Author Affiliations

1: Department of Dermatology II, Department of Pathology II, Hospital Central de Asturias, University of Oviedo, Spain.

Articles by these authors

In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. Hum Gene Ther (1997) 1.53

Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer. Cancer Invest (2002) 1.50

[Corticoid treatment in Castleman's disease]. Med Clin (Barc) (1995) 1.39

Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma. Cancer (1997) 1.39

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein. J Immunol (2001) 1.28

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res (1999) 1.28

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein. Cancer Res (1999) 1.26

Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. J Immunol (1998) 1.10

Assessing oncologic benefit in clinical trials of immunotherapy agents. Ann Oncol (2010) 1.07

alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. Cancer Res (2001) 1.07

[Experimental orthopic liver transplant]. Rev Esp Enferm Apar Dig (1972) 1.06

Geography and host biogeography matter for understanding the phylogeography of a parasite. Mol Phylogenet Evol (2008) 1.05

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein. Mol Immunol (2000) 0.98

p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. Cancer Res (1999) 0.97

Nodular primary localized cutaneous amyloidosis. J Eur Acad Dermatol Venereol (2004) 0.97

Multiple G proteins and phospholipase C isoforms in human myometrial cells: implication for oxytocin action. J Clin Endocrinol Metab (1996) 0.96

Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California. Pigment Cell Melanoma Res (2013) 0.95

Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis. Anticancer Res (1996) 0.95

[Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients]. Actas Dermosifiliogr (2011) 0.94

Protozoa in respiratory pathology: a review. Eur Respir J (2008) 0.92

Antispasmodic effects of hydroalcoholic extract of Marrubium vulgare on isolated tissues. Phytomedicine (1996) 0.89

Desensitization of oxytocin receptors in human myometrium. Hum Reprod Update (1999) 0.89

The desensitization of oxytocin receptors in human myometrial cells is accompanied by down-regulation of oxytocin receptor messenger RNA. J Endocrinol (1997) 0.88

EuroBionet: a pan-European biomonitoring network for urban air quality assessment. Environ Sci Pollut Res Int (2002) 0.87

Acneiform lesions in Becker's nevus and breast hypoplasia. Int J Dermatol (2002) 0.86

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy. Cancer (1992) 0.85

24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures. Addict Biol (2002) 0.85

Encapsulated fat necrosis: a form of traumatic panniculitis. J Eur Acad Dermatol Venereol (2007) 0.83

Acral ulcerations and osteolysis, a severe form of the carpal tunnel syndrome. Br J Dermatol (2004) 0.83

Helminth communities of the exotic introduced turtle, Trachemys scripta elegans in southwestern Spain: Transmission from native turtles. Res Vet Sci (2008) 0.81

Choline kinase active site provides features for designing versatile inhibitors. Curr Top Med Chem (2014) 0.81

PET imaging of the immune system: immune monitoring at the whole body level. Q J Nucl Med Mol Imaging (2010) 0.81

Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector. Anticancer Res (1998) 0.81

Helminths of the wild rabbit (Oryctolagus cuniculus) in Macaronesia. J Parasitol (2003) 0.81

Oxytocin signalling in human myometrium. Adv Exp Med Biol (1995) 0.81

Cutaneous granulomas caused by corynebacterium minutissimum in an HIV-infected man. J Eur Acad Dermatol Venereol (2002) 0.80

Results of two sequential chemotherapy studies in WHO Types I, III and IV lung cancer: cyclophosphamide-5-fluorouracil (CF) and cyclophosphamide-5-fluorouracil-adriamycin (CAF). Eur J Cancer (1979) 0.79

Isolation, characterization and PCR multiplexing of polymorphic microsatellite markers in the edible dormouse, Glis glis. Mol Ecol Resour (2009) 0.78

Should people with hepatitis C virus infection receive a bone marrow transplant? Bone Marrow Transplant (1997) 0.78

[Psoriasiform skin reactions during treatment with etanercept]. Actas Dermosifiliogr (2010) 0.78

Primary cutaneous extraskeletal osteosarcoma under a previous electrodessicated actinic keratosis. J Am Acad Dermatol (2004) 0.78

Notocotylus loeiensis N. sp. (Trematoda: Notocotylidae) from Rattus losea (Rodentia: Muridae) in Thailand. Parasite (2011) 0.77

Ethanol and lipid metabolism. Differential effects on liver and brain microsomes. FEBS Lett (1991) 0.77

[Transient thrombocytopenia probably induced by isotretinoin]. Actas Dermosifiliogr (2008) 0.77

Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells. Cancer Res (2000) 0.76

Development of familial benign chronic pemphigus in a patient undergoing treatment with efalizumab for psoriasis. J Eur Acad Dermatol Venereol (2008) 0.76

Amoxicillin-associated linear IgA bullous dermatosis. J Eur Acad Dermatol Venereol (2007) 0.75

Re: Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support. J Natl Cancer Inst (1997) 0.75

Pigmented actinic lichen planus successfully treated with intense pulsed light. Br J Dermatol (2010) 0.75

[Fine-needle puncture aspiration as a diagnostic method in superficial masses. Experience at the Hospital General de Asturias]. Rev Clin Esp (1983) 0.75

[Fixed, generalized exanthema caused by thiabendazole]. Actas Dermosifiliogr (1983) 0.75

Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study. Eur J Cancer (1978) 0.75

Comparative study of sequential combinations of paclitaxel and methotrexate on a human bladder cancer cell line. Cancer Invest (2000) 0.75

[Treatment response and long term survival of a patient seropositive for the human immunodeficiency virus with non-Hodgkin's lymphoma]. Sangre (Barc) (1994) 0.75

M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladder. Am J Clin Oncol (1996) 0.75

What is the role of recombinant colony stimulating factors in bone marrow transplantation? Bone Marrow Transplant (1990) 0.75

[Dementias in the primary care setting]. Aten Primaria (1997) 0.75

Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer. Cancer (1995) 0.75

[Is bronchial asthma an infectious disease?]. Arch Bronconeumol (1999) 0.75

A late complication of tracheostomy. Wis Med J (1977) 0.75

Persistence of the effects of ethanol in vitro on the lipid order and enzyme activities of chick-liver membranes. Eur J Pharmacol (1995) 0.75

[Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)]. Arch Esp Urol (1996) 0.75

[Giant-cell arteritis of temporal localization and hepatic granulomatosis]. Rev Clin Esp (1977) 0.75

[Eruptive hidradenoma]. Actas Dermosifiliogr (1983) 0.75

Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis. Cancer Chemother Pharmacol (1997) 0.75

[The consumption of drugs and natural remedies in the older population of a rural area]. Aten Primaria (1999) 0.75

The shifting patterns of metastatic melanoma. Clin Lab Med (2000) 0.75

Hematopoietic growth factors in bone marrow transplantation: current and future directions. Haematologica (1991) 0.75

[Recurrent strokes and skin macules]. Rev Clin Esp (2005) 0.75

[Pruriginous cutaneous plaque]. An Pediatr (Barc) (2003) 0.75

[Gene therapy: new prospects in the treatment of cancer]. Med Clin (Barc) (1994) 0.75

Varicella complicated by group A streptococcal facial cellulitis. J Am Acad Dermatol (2001) 0.75

Hyperphosphatasemia: CT assessment. Eur Radiol (1997) 0.75

[Initial clinicopathological manifestations of malignant lymphoproliferative processes in patients with human immunodeficiency virus seropositivity. Study of 40 cases]. An Med Interna (1994) 0.75

[Cystic disease of the popliteal artery: presentation of a case with subintimal localization]. Angiologia (1986) 0.75

Iron toxicity studies of quelamycin. Cancer Treat Rep (1979) 0.75

[The ISCA (Systematic Interview of Alcohol Consumption), a new instrument to detect risky drinking]. Med Clin (Barc) (2001) 0.75

The helminth community of Talpa romana (Thomas, 1902) (Insectivora, Talpidae) in southern Italy. Parasitol Res (2002) 0.75

[Acute hemorrhagic infantile edema]. Actas Dermosifiliogr (1983) 0.75

[Erythema and hand desquamation. Paraneoplastic acrokeratosis (Bazex syndrome)]. Rev Clin Esp (2001) 0.75